Will Congress Commit to Investing in Brain Disease?
Every year, millions of people suffer from a brain disease, disorder or injury. Yet research on these conditions remains complex and sometimes frustrating.
Congressional Momentum Builds for Telehealth Expansion
Legislation to expand access to telehealth services is likely to pass Congress this year. But what exactly will it entail?
Patients Pay the Price When Insurers Switch Mental Health Medications
More than 53 million American adults live with mental illness, and one in six take prescription medication to treat it.
Making Hepatitis C History
By Robert Gish, MD As the country continues to battle one infectious disease, health officials are simultaneously refocusing efforts to wipe another off the map thanks to medical innovation. Getting Cured is Cost Saving Compared to treating some COVID-19 infections, treating hepatitis C is easy. Direct-acting antivirals are taken orally and have a low risk […]
Rare but Not Alone: 1 in 10 Live with a Rare Disease
The 30 million Americans diagnosed with a rare disease represent a large, underserved patient population. Their complex conditions are often poorly understood, and most have no approved treatment.
Addressing Unmet Needs in Peripheral Artery Disease
As an aging America faces rising rates of obesity and diabetes, people may also find themselves facing a dangerous cardiovascular disease.
Comments on ICER’s Draft Evidence Report on Plinabulin and Trilaciclib Chemotherapy-Induced Neutropenia
ICER has announced its intent to issue a final evidence report in this review without first holding a public hearing, a highly unusual decision.
Patients Snubbed by Health Economists
Even after vowing to expand patients’ engagement in its process, the nation’s most active health technology assessment organization has shut them out.
When Patients Get Edged Out by Profits
Patients, alongside their health care providers, should decide which medication is right for them. Yet, with increasing frequency, that decision is being overruled by “the middleman.”
Cystic Fibrosis Patients’ Annual Fight for Access to Treatment
Most patients with cystic fibrosis are just wrapping up an annual hassle of the new year – that of confirming their insurance will still cover the medications they need. It’s a process known as insurance reauthorization.
